Cat.#: ACPP-1214
| Despition | Ki67 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg | inquiry |
| ACPP-1769 | Human VAT1 Protein (AC1769) | 2 µg | inquiry |
| ACPP-1658 | Human Acrp30 Protein, His (AC1658) | 10 µg | inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1806 | Human SCGN Protein (AC1806) | 2 µg | inquiry |
| ACPP-1156 | Recombinant Human GnRHR Protein (Fc Tag) (AC1156) | 50 µg | inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.